SCHEMBL7473464

SCHEMBL7473464

CC(=C[C@@H](Cc1ccc2ccccc2c1)N(C)C(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSB P07858 2/20 0.45
CTSS P25774 2/20 0.45
CTSK P43235 1/20 0.45
PTPN1 P18031 2/20 0.41
MAOB P27338 1/20 0.41
GHSR Q92847 3/20 0.40
TACR1 P25103 1/20 0.39
MMP9 P14780 1/20 0.38
MMP8 P22894 1/20 0.38
MME P08473 1/20 0.38
ACE P12821 1/20 0.38
SLC1A3 P43003 1/20 0.37
SLC1A2 P43004 1/20 0.37
SLC1A1 P43005 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
CTSL P07711 1/20 0.36
PSMB5 P28074 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8359762 0.85 CTSB (0.46) CTSBCTSSCTSKPTPN1MAOB
SCHEMBL7475243 0.85 CTSB (0.46) CTSBCTSSCTSKPTPN1MAOB
SCHEMBL3266674 0.80 CTSB (0.49) CTSBCTSSCTSKPTPN1MAOB
SCHEMBL7286769 0.80 CTSB (0.49) CTSBCTSSCTSKPTPN1MAOB
SCHEMBL29624575 0.80 CTSB (0.49) CTSBCTSSCTSKPTPN1MAOB
SCHEMBL1401196 0.80 CTSB (0.49) CTSBCTSSCTSKPTPN1MAOB
SCHEMBL31407327 0.80 CTSB (0.49) CTSBCTSSCTSKPTPN1MAOB
SCHEMBL8362266 0.78 CTSB (0.41) CTSBCTSSCTSKPTPN1GHSR
SCHEMBL5428769 0.77 MCHR1 (0.42) TACR1
SCHEMBL8717981 0.76 CTSB (0.47) CTSBCTSSCTSKPTPN1GHSR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0923550-B1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS NOVARTIS AG (CH) 2002-09-25 EP disclosed
US-6319917-B1 NEUROGENIC INFLAMMATION AND TACHYKININ BRONCHOCONSTRICTION INHIBITORS NOVARTIS AG (CH) 2001-11-20 US disclosed
EP-0923550-A1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS Novartis AG (CH) 1999-06-23 EP disclosed
WO-1998007694-A1 ACYLAMINOALKENYLENE-AMIDE DERIVATIVES AS NK1 AND NK2 ANTAGONISTS NOVARTIS AG (CH) 1998-02-26 WO disclosed